Astellas Archives -

Shot in the arm for Affinivax as it challenges Pfizer’s Prevnar

https://pharmaphorum.com/news/shot-in-the-arm-for-affinivax-as-it-challenges-pfizers-prevnar/

New Cell & Gene Therapy Collective seeks to boost UK adoption

https://pharmaphorum.com/views-and-analysis/new-cell-gene-therapy-collective-seeks-to-boost-uk-adoption/

Astellas, Seagen seek speedy reviews of Padcev in bladder cancer

https://pharmaphorum.com/news/astellas-seagen-seek-speedy-reviews-of-padcev-in-bladder-cancer/

Global impact: How regulatory affairs is shaping development of cutting-edge pharma innovation

https://pharmaphorum.com/views-and-analysis/global-impact-how-regulatory-affairs-is-shaping-development-of-cutting-edge-pharma-innovation/

Astellas/Seagen prepare full US filing of bladder cancer drug Padcev

https://pharmaphorum.com/news/astellas-seagen-to-prepare-for-full-us-filing-of-bladder-cancer-drug-padcev/

Astellas doubles down on partnership and buys bioelectronics firm iota

https://pharmaphorum.com/news/astellas-doubles-down-on-partnership-and-buys-bioelectronics-firm-iota/

https://pharmaphorum.com/news/nice-backs-nhs-use-for-astellas-xospata-after-rethink/

GSK’s kidney disease anaemia drug approved in Japan, taking on Astellas’ rival

https://pharmaphorum.com/news/gsk-kidney-disease-anaemia-drug-approved-in-japan-taking-on-astellas-rival/

Seattle Genetics says data backs Padcev combo for first-line bladder cancer

https://pharmaphorum.com/news/seattle-genetics-says-data-backs-padcev-combo-for-first-line-bladder-cancer/

Search